Provided by Tiger Fintech (Singapore) Pte. Ltd.

Integra Lifesciences

16.81
+0.11000.66%
Post-market: 16.810.00000.00%17:20 EDT
Volume:758.56K
Turnover:12.64M
Market Cap:1.30B
PE:-186.43
High:16.86
Open:16.66
Low:16.27
Close:16.70
Loading ...

Company Profile

Company Name:
Integra Lifesciences
Exchange:
NASDAQ
Establishment Date:
1989
Employees:
4396
Office Location:
1100 Campus Road,Princeton,New Jersey,United States
Zip Code:
08540
Fax:
609 750 4277
Introduction:
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Directors

Name
Position
Jan D. De Witte
President and Chief Executive Officer and Director
Stuart M. Essig
Chairman of the Board
Barbara B. Hill
Director
Christian S. Schade
Director
Donald E. Morel, Jr.
Director
Keith Bradley
Director
Raymond G. Murphy
Director
Shaundra D. Clay
Director

Shareholders

Name
Position
Jan D. De Witte
President and Chief Executive Officer and Director
Glenn G. Coleman
Executive Vice President and Chief Operating Officer
Carrie L. Anderson
Executive Vice President and Chief Financial Officer
Jeffrey Mosebrook
Senior Vice President and Principal Accounting Officer
Eric I. Schwartz
Executive Vice President, Chief Legal Officer and Secretary
Lisa Evoli
Executive Vice President and Chief Human Resources Officer
Michael McBreen
Executive Vice President, President, Codman Specialty Surgical
Robert T. Davis, Jr.
Executive Vice President, President, Tissue Technologies